awacke1/LOINC-Clinical-Terminology · Datasets at Hugging Face

LOINC_NUM stringlengths 3 8	COMPONENT stringlengths 2 246	PROPERTY stringlengths 1 29	TIME_ASPCT stringlengths 1 15	SYSTEM stringlengths 1 106	SCALE_TYP stringclasses 10 values	METHOD_TYP stringlengths 1 57 ⌀	CLASS stringlengths 2 24	CLASSTYPE int64 1 4	LONG_COMMON_NAME stringlengths 3 254	SHORTNAME stringlengths 2 51 ⌀	EXTERNAL_COPYRIGHT_NOTICE stringlengths 39 2.6k ⌀	STATUS stringclasses 4 values	VersionFirstReleased stringlengths 1 7	VersionLastChanged stringlengths 1 5
93246-7	Wish to be dead	Find	1Mo	^Patient	Ord	null	SURVEY.CSSRS	4	Wish to be dead 1 month	null	null	ACTIVE	2.67	2.67
93247-5	Non-specific active suicidal thoughts	Find	1Mo	^Patient	Ord	null	SURVEY.CSSRS	4	Non-specific active suicidal thoughts 1 month	null	null	ACTIVE	2.67	2.67
93248-3	Active suicidal ideation with any methods (not plan) without intent to act	Find	1Mo	^Patient	Ord	null	SURVEY.CSSRS	4	Active suicidal ideation with any methods (not plan) without intent to act 1 month	null	null	ACTIVE	2.67	2.67
93249-1	Active suicidal ideation with some intent to act, without specific plan	Find	1Mo	^Patient	Ord	null	SURVEY.CSSRS	4	Active suicidal ideation with some intent to act, without specific plan 1 month	null	null	ACTIVE	2.67	2.67
93250-9	Active suicidal ideation with specific plan and intent	Find	1Mo	^Patient	Ord	null	SURVEY.CSSRS	4	Active suicidal ideation with specific plan and intent 1 month	null	null	ACTIVE	2.67	2.67
93251-7	Duration of most severe suicidal ideation	Find	Lifetime	^Patient	Ord	C-SSRS	SURVEY.CSSRS	4	Duration of most severe suicidal ideation Lifetime [C-SSRS]	null	© 2008 Research Foundation of Mental Hygiene, Inc. Used with permission	ACTIVE	2.67	2.67
9325-2	Tryptophan	SCnc	24H	Urine	Qn	null	CHEM	1	Tryptophan [Moles/volume] in 24 hour Urine	Tryptophan 24h Ur-sCnc	null	ACTIVE	1.0i	2.7
93252-5	Duration of most severe suicidal ideation	Find	1Mo	^Patient	Ord	C-SSRS	SURVEY.CSSRS	4	Duration of most severe suicidal ideation 1 month [C-SSRS]	null	© 2008 Research Foundation of Mental Hygiene, Inc. Used with permission	ACTIVE	2.67	2.67
93253-3	Actual suicide attempt	Find	Lifetime	^Patient	Ord	null	SURVEY.CSSRS	4	Actual suicide attempt Lifetime	null	null	ACTIVE	2.67	2.67
93254-1	Actual suicide attempts	Num	Lifetime	^Patient	Qn	null	SURVEY.CSSRS	4	Actual suicide attempts # Lifetime	null	null	ACTIVE	2.67	2.67
93255-8	Actual suicide attempt	Find	3Mo	^Patient	Ord	null	SURVEY.CSSRS	4	Actual suicide attempt 3 months	null	null	ACTIVE	2.67	2.67
93256-6	Actual suicide attempts	Num	3Mo	^Patient	Qn	null	SURVEY.CSSRS	4	Actual suicide attempts # 3 months	null	null	ACTIVE	2.67	2.67
93257-4	Has subject engaged in non-suicidal self-injurious behavior	Find	Lifetime	^Patient	Ord	null	SURVEY.CSSRS	4	Has subject engaged in non-suicidal self-injurious behavior Lifetime	null	null	ACTIVE	2.67	2.67
93258-2	Has subject engaged in non-suicidal self-injurious behavior	Find	3Mo	^Patient	Ord	null	SURVEY.CSSRS	4	Has subject engaged in non-suicidal self-injurious behavior 3 months	null	null	ACTIVE	2.67	2.67
93259-0	Interrupted suicide attempt	Find	Lifetime	^Patient	Ord	null	SURVEY.CSSRS	4	Interrupted suicide attempt Lifetime	null	null	ACTIVE	2.67	2.67
9326-0	Phosphatidylserine Ab.IgG	PrThr	Pt	Ser	Ord	IA	COAG	1	Phosphatidylserine IgG Ab [Presence] in Serum by Immunoassay	PS IgG Ser Ql IA	null	ACTIVE	1.0i	2.73
93260-8	Interrupted suicide attempts	Num	Lifetime	^Patient	Qn	null	SURVEY.CSSRS	4	Interrupted suicide attempts # Lifetime	null	null	ACTIVE	2.67	2.67
93261-6	Interrupted suicide attempt	Find	3Mo	^Patient	Ord	null	SURVEY.CSSRS	4	Interrupted suicide attempt 3 months	null	null	ACTIVE	2.67	2.67
93262-4	Interrupted suicide attempts	Num	3Mo	^Patient	Qn	null	SURVEY.CSSRS	4	Interrupted suicide attempts # 3 months	null	null	ACTIVE	2.67	2.67
93263-2	Aborted or self-interrupted suicide attempt	Find	Lifetime	^Patient	Ord	null	SURVEY.CSSRS	4	Aborted or self-interrupted suicide attempt Lifetime	null	null	ACTIVE	2.67	2.67
93264-0	Aborted or self-interrupted suicide attempts	Num	Lifetime	^Patient	Qn	null	SURVEY.CSSRS	4	Aborted or self-interrupted suicide attempts # Lifetime	null	null	ACTIVE	2.67	2.67
93265-7	Aborted or self-interrupted suicide attempt	Find	3Mo	^Patient	Ord	null	SURVEY.CSSRS	4	Aborted or self-interrupted suicide attempt 3 months	null	null	ACTIVE	2.67	2.67
93266-5	Aborted or self-interrupted suicide attempts	Num	3Mo	^Patient	Qn	null	SURVEY.CSSRS	4	Aborted or self-interrupted suicide attempts # 3 months	null	null	ACTIVE	2.67	2.67
93267-3	Preparatory acts or suicidal behavior	Find	Lifetime	^Patient	Ord	null	SURVEY.CSSRS	4	Preparatory acts or suicidal behavior Lifetime	null	null	ACTIVE	2.67	2.67
93268-1	Preparatory acts or suicidal behaviors	Num	Lifetime	^Patient	Qn	null	SURVEY.CSSRS	4	Preparatory acts or suicidal behaviors # Lifetime	null	null	ACTIVE	2.67	2.67
93269-9	Preparatory acts or suicidal behavior	Find	3Mo	^Patient	Ord	null	SURVEY.CSSRS	4	Preparatory acts or suicidal behavior 3 months	null	null	ACTIVE	2.67	2.67
93270-7	Preparatory acts or suicidal behaviors	Num	3Mo	^Patient	Ord	null	SURVEY.CSSRS	4	Preparatory acts or suicidal behaviors # 3 months	null	null	ACTIVE	2.67	2.67
93271-5	Actual lethality or medical damage most lethal suicide attempt	Find	Lifetime	^Patient	Ord	C-SSRS	SURVEY.CSSRS	4	Actual lethality/medical damage most lethal suicide attempt Lifetime [C-SSRS]	null	© 2008 Research Foundation of Mental Hygiene, Inc. Used with permission	ACTIVE	2.67	2.67
93272-3	Potential lethality most lethal suicide attempt	Find	Lifetime	^Patient	Ord	C-SSRS	SURVEY.CSSRS	4	Potential lethality most lethal suicide attempt Lifetime [C-SSRS]	null	© 2008 Research Foundation of Mental Hygiene, Inc. Used with permission	ACTIVE	2.67	2.67
93275-6	Date of most lethal suicide attempt	Date	Pt	^Patient	Qn	null	SURVEY.CSSRS	4	Date of most lethal suicide attempt	null	null	ACTIVE	2.67	2.67
9327-8	Phosphatidylserine Ab.IgM	PrThr	Pt	Ser	Ord	IA	COAG	1	Phosphatidylserine IgM Ab [Presence] in Serum by Immunoassay	PS IgM Ser Ql IA	null	ACTIVE	1.0i	2.73
93278-0	Suicidal ideation	-	Pt	^Patient	-	C-SSRS	PANEL.SURVEY.CSSRS	4	Suicidal ideation [C-SSRS]	null	© 2008 Research Foundation of Mental Hygiene, Inc. Used with permission	ACTIVE	2.67	2.67
93279-8	Most severe suicidal ideation description	Find	1Mo	^Patient	Nom	null	SURVEY.CSSRS	4	Most severe suicidal ideation description 1 month	null	null	ACTIVE	2.67	2.67
93280-6	Most severe suicidal ideation description	Find	Lifetime	^Patient	Nom	null	SURVEY.CSSRS	4	Most severe suicidal ideation description Lifetime	null	null	ACTIVE	2.67	2.67
93281-4	Potential lethality initial or first suicide attempt	Find	Pt	^Patient	Ord	C-SSRS	SURVEY.CSSRS	4	Potential lethality initial/first suicide attempt [C-SSRS]	null	© 2008 Research Foundation of Mental Hygiene, Inc. Used with permission	ACTIVE	2.67	2.67
93282-2	Potential lethality most recent suicide attempt	Find	Pt	^Patient	Ord	C-SSRS	SURVEY.CSSRS	4	Potential lethality most recent suicide attempt [C-SSRS]	null	© 2008 Research Foundation of Mental Hygiene, Inc. Used with permission	ACTIVE	2.67	2.67
93283-0	Actual lethality or medical damage initial or first suicide attempt	Find	Pt	^Patient	Ord	C-SSRS	SURVEY.CSSRS	4	Actual lethality/medical damage initial/first suicide attempt type [C-SSRS]	null	© 2008 Research Foundation of Mental Hygiene, Inc. Used with permission	ACTIVE	2.67	2.67
93284-8	Actual lethality or medical damage most recent suicide attempt	Find	Pt	^Patient	Ord	C-SSRS	SURVEY.CSSRS	4	Actual lethality/medical damage most recent suicide attempt [C-SSRS]	null	© 2008 Research Foundation of Mental Hygiene, Inc. Used with permission	ACTIVE	2.67	2.67
93285-5	Reasons for most severe suicidal ideation	Find	1Mo	^Patient	Ord	C-SSRS	SURVEY.CSSRS	4	Reasons for most severe suicidal ideation 1 month [C-SSRS]	null	© 2008 Research Foundation of Mental Hygiene, Inc. Used with permission	ACTIVE	2.67	2.67
9328-6	Carbidopa	MCnc	Pt	Ser/Plas	Qn	null	DRUG/TOX	1	Carbidopa [Mass/volume] in Serum or Plasma	Carbidopa SerPl-mCnc	null	ACTIVE	1.0i	2.73
93286-3	Reasons for most severe suicidal ideation	Find	Lifetime	^Patient	Ord	C-SSRS	SURVEY.CSSRS	4	Reasons for most severe suicidal ideation Lifetime [C-SSRS]	null	© 2008 Research Foundation of Mental Hygiene, Inc. Used with permission	ACTIVE	2.67	2.67
93287-1	Deterrents of most severe suicidal ideation	Find	1Mo	^Patient	Ord	C-SSRS	SURVEY.CSSRS	4	Deterrents of most severe suicidal ideation 1 month [C-SSRS]	null	© 2008 Research Foundation of Mental Hygiene, Inc. Used with permission	ACTIVE	2.67	2.67
93288-9	Deterrents of most severe suicidal ideation	Find	Lifetime	^Patient	Ord	C-SSRS	SURVEY.CSSRS	4	Deterrents of most severe suicidal ideation Lifetime [C-SSRS]	null	© 2008 Research Foundation of Mental Hygiene, Inc. Used with permission	ACTIVE	2.67	2.67
93289-7	Controllability of most severe suicidal ideation	Find	1Mo	^Patient	Ord	C-SSRS	SURVEY.CSSRS	4	Controllability of most severe suicidal ideation 1 month [C-SSRS]	null	© 2008 Research Foundation of Mental Hygiene, Inc. Used with permission	ACTIVE	2.67	2.67
93290-5	Controllability of most severe suicidal ideation	Find	Lifetime	^Patient	Ord	C-SSRS	SURVEY.CSSRS	4	Controllability of most severe suicidal ideation Lifetime [C-SSRS]	null	© 2008 Research Foundation of Mental Hygiene, Inc. Used with permission	ACTIVE	2.67	2.67
93291-3	Frequency of most severe suicidal ideation	Find	1Mo	^Patient	Ord	C-SSRS	SURVEY.CSSRS	4	Frequency of most severe suicidal ideation 1 month [C-SSRS]	null	© 2008 Research Foundation of Mental Hygiene, Inc. Used with permission	ACTIVE	2.67	2.67
93292-1	Frequency of most severe suicidal ideation	Find	Lifetime	^Patient	Ord	C-SSRS	SURVEY.CSSRS	4	Frequency of most severe suicidal ideation Lifetime [C-SSRS]	null	© 2008 Research Foundation of Mental Hygiene, Inc. Used with permission	ACTIVE	2.67	2.67
93293-9	Most severe suicidal ideation	Type	1Mo	^Patient	Ord	null	SURVEY.CSSRS	4	Most severe suicidal ideation 1 month	null	null	ACTIVE	2.67	2.67
9329-4	Basement membrane Ab	ACnc	Pt	Ser	Qn	IA	SERO	1	Basement membrane Ab [Units/volume] in Serum by Immunoassay	BM Ab Ser IA-aCnc	null	ACTIVE	1.0i	2.73
93294-7	Most severe suicidal ideation	Type	Lifetime	^Patient	Ord	null	SURVEY.CSSRS	4	Most severe suicidal ideation Lifetime	null	null	ACTIVE	2.67	2.67
93295-4	Active suicidal ideation with specific plan and intent	Find	Lifetime	^Patient	Ord	null	SURVEY.CSSRS	4	Active suicidal ideation with specific plan and intent Lifetime	null	null	ACTIVE	2.67	2.67
93296-2	Active suicidal ideation with some intent to act, without specific plan	Find	Lifetime	^Patient	Ord	null	SURVEY.CSSRS	4	Active suicidal ideation with some intent to act, without specific plan Lifetime	null	null	ACTIVE	2.67	2.67
93297-0	Active suicidal ideation with any methods (not plan) without intent to act	Find	Lifetime	^Patient	Ord	null	SURVEY.CSSRS	4	Active suicidal ideation with any methods (not plan) without intent to act Lifetime	null	null	ACTIVE	2.67	2.67
93298-8	Non-specific active suicidal thoughts	Find	Lifetime	^Patient	Ord	null	SURVEY.CSSRS	4	Non-specific active suicidal thoughts Lifetime	null	null	ACTIVE	2.67	2.7
93299-6	Wish to be dead	Find	Lifetime	^Patient	Ord	null	SURVEY.CSSRS	4	Wish to be dead Lifetime	null	null	ACTIVE	2.67	2.7
93301-0	Date of initial or first suicide attempt	Date	Pt	^Patient	Qn	null	SURVEY.CSSRS	4	Date of initial/first suicide attempt	null	null	ACTIVE	2.67	2.67
9330-2	Benzene	MCnc	Pt	Bld	Qn	null	DRUG/TOX	1	Benzene [Mass/volume] in Blood	Benzene Bld-mCnc	null	ACTIVE	1.0i	2.73
93302-8	Date of most recent suicide attempt	Date	Pt	^Patient	Qn	null	SURVEY.CSSRS	4	Date of most recent suicide attempt	null	null	ACTIVE	2.67	2.67
93303-6	Intensity of ideation	-	Pt	^Patient	-	C-SSRS	PANEL.SURVEY.CSSRS	4	Intensity of ideation [C-SSRS]	null	© 2008 Research Foundation of Mental Hygiene, Inc. Used with permission	ACTIVE	2.67	2.67
93304-4	Suicidal behavior	-	Pt	^Patient	-	C-SSRS	PANEL.SURVEY.CSSRS	4	Suicidal behavior [C-SSRS]	null	© 2008 Research Foundation of Mental Hygiene, Inc. Used with permission	ACTIVE	2.67	2.68
93305-1	Lethality	-	Pt	^Patient	-	C-SSRS	PANEL.SURVEY.CSSRS	4	Lethality [C-SSRS]	null	© 2008 Research Foundation of Mental Hygiene, Inc. Used with permission	ACTIVE	2.67	2.67
93306-9	Genetic risk score for coronary heart disease	Score	Lifetime	^Patient	Qn	null	CLIN.RISK	2	Genetic risk score for coronary heart disease	GRS for CHD	null	ACTIVE	2.67	2.67
93307-7	Lifetime risk for developing coronary heart disease based on genetic risk score	Likelihood	Lifetime	^Patient	Ord	null	CLIN.RISK	2	Lifetime risk for developing coronary heart disease based on genetic risk score	Lifetime Risk for CHD based on GRS	null	ACTIVE	2.67	2.67
93308-5	Risk of adverse drug reaction sequence variation interpretation	Imp	Pt	Bld/Tiss	Nar	null	MOLPATH.PHARMG	1	Genetic variation's effect on risk of adverse drug reaction	Adverse drug seq var interp Bld/T-Imp	null	TRIAL	2.67	2.67
93309-3	Hearing.ability to hear during 3D assessment period	Find	3D	^Patient	Ord	CMS Assessment	SURVEY.CMS	4	Hearing.ability to hear during 3 day assessment period [CMS Assessment]	null	null	ACTIVE	2.67	2.67
9331-0	Boron	MCnc	Pt	Urine	Qn	null	DRUG/TOX	1	Boron [Mass/volume] in Urine	Boron Ur-mCnc	null	ACTIVE	1.0i	2.73
93310-1	Vision.ability to see in adequate light during 3D assessment period	Find	3D	^Patient	Ord	CMS Assessment	SURVEY.CMS	4	Vision.ability to see in adequate light during 3 day assessment period [CMS Assessment]	null	null	ACTIVE	2.67	2.67
93313-5	Platelet glycoprotein disorder	Imp	Pt	Bld	Nar	Flow cytometry	CELLMARK	1	Platelet glycoprotein disorder [Interpretation] in Blood by Flow cytometry (FC) Narrative	Platelet GP disorder Bld FC-Imp	null	ACTIVE	2.67	2.67
93314-3	Platelet glycoprotein VI actual/normal	RelRto	Pt	Bld	Qn	Flow cytometry	CELLMARK	1	Platelet glycoprotein VI actual/normal in Blood by Flow cytometry (FC)	Plt GPVI Act/Nor Bld FC	null	ACTIVE	2.67	2.67
93315-0	Platelet CD49b actual/normal	RelRto	Pt	Bld	Qn	Flow cytometry	CELLMARK	1	Platelet CD49b actual/normal in Blood by Flow cytometry (FC)	Plt CD49b Act/Nor Bld FC	null	ACTIVE	2.67	2.67
93316-8	Platelet CD42b actual/normal	RelRto	Pt	Bld	Qn	Flow cytometry	CELLMARK	1	Platelet CD42b actual/normal in Blood by Flow cytometry (FC)	Plt CD42b Act/Nor Bld FC	null	ACTIVE	2.67	2.67
93317-6	Platelet CD42a actual/normal	RelRto	Pt	Bld	Qn	Flow cytometry	CELLMARK	1	Platelet CD42a actual/normal in Blood by Flow cytometry (FC)	Plt CD42a Act/Nor Bld FC	null	ACTIVE	2.67	2.67
93318-4	Platelet CD61 actual/normal	RelRto	Pt	Bld	Qn	Flow cytometry	CELLMARK	1	Platelet CD61 actual/normal in Blood by Flow cytometry (FC)	Plt CD61 Act/Nor Bld FC	null	ACTIVE	2.67	2.67
93319-2	Platelet CD41 actual/normal	RelRto	Pt	Bld	Qn	Flow cytometry	CELLMARK	1	Platelet CD41 actual/normal in Blood by Flow cytometry (FC)	Plt CD41 Act/Nor Bld FC	null	ACTIVE	2.67	2.67
933-2	Blood product type	Type	Pt	^BPU	Nom	null	BLDBK	1	Blood product type	Bld Prod Typ BPU	null	ACTIVE	1.0	2.73
93320-0	Platelet glycoprotein disorder panel	-	Pt	Bld	Qn	Flow cytometry	PANEL.CELLMARK	1	Platelet surface glycoprotein disorders panel - Blood by Flow cytometry (FC)	Platelet glycoprotein Pnl Bld FC	null	ACTIVE	2.67	2.67
93321-8	PT mixing study panel	-	Pt	PPP	Qn	Coag	PANEL.COAG	1	PT mixing study panel - Platelet poor plasma by Coagulation assay	PT mix Pnl PPP	null	ACTIVE	2.67	2.67
93323-4	Tauroursodeoxycholate	SCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Tauroursodeoxycholate [Moles/volume] in Serum or Plasma	TUDCA SerPl-sCnc	null	ACTIVE	2.67	2.67
93324-2	Taurolithocholate	SCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Taurolithocholate [Moles/volume] in Serum or Plasma	TLCA SerPl-sCnc	null	ACTIVE	2.67	2.67
93325-9	Taurohyodeoxycholate	SCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Taurohyodeoxycholate [Moles/volume] in Serum or Plasma	THDCA SerPl-sCnc	null	ACTIVE	2.67	2.67
93326-7	Taurodeoxycholate	SCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Taurodeoxycholate [Moles/volume] in Serum or Plasma	TDCA SerPl-sCnc	null	ACTIVE	2.67	2.67
93327-5	Taurocholate	SCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Taurocholate [Moles/volume] in Serum or Plasma	TCA SerPl-sCnc	null	ACTIVE	2.67	2.67
9332-8	Carbon tetrachloride	MCnc	Pt	Bld	Qn	null	DRUG/TOX	1	Carbon tetrachloride [Mass/volume] in Blood	Carbon Tet Bld-mCnc	null	ACTIVE	1.0i	2.73
93328-3	Taurochenodeoxycholate	SCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Taurochenodeoxycholate [Moles/volume] in Serum or Plasma	TCDCA SerPl-sCnc	null	ACTIVE	2.67	2.67
93329-1	Hyodeoxycholate	SCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Hyodeoxycholate [Moles/volume] in Serum or Plasma	HDCA SerPl-sCnc	null	ACTIVE	2.67	2.67
93330-9	Glycoursodeoxycholate	SCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Glycoursodeoxycholate [Moles/volume] in Serum or Plasma	GUDCA SerPl-sCnc	null	ACTIVE	2.67	2.67
93331-7	Glycolithocholate	SCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Glycolithocholate [Moles/volume] in Serum or Plasma	GLCA SerPl-sCnc	null	ACTIVE	2.67	2.67
93332-5	Glycohyodeoxycholate	SCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Glycohyodeoxycholate [Moles/volume] in Serum or Plasma	Glycohyodeoxycholate SerPl-sCnc	null	ACTIVE	2.67	2.67
93333-3	Glycodeoxycholate	SCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Glycodeoxycholate [Moles/volume] in Serum or Plasma	GDCA SerPl-sCnc	null	ACTIVE	2.67	2.67
93334-1	Glycocholate	SCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Glycocholate [Moles/volume] in Serum or Plasma	GCA SerPl-sCnc	null	ACTIVE	2.67	2.67
93335-8	Glycochenodeoxycholate	SCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Glycochenodeoxycholate [Moles/volume] in Serum or Plasma	GCDCA SerPl-sCnc	null	ACTIVE	2.67	2.67
9333-6	Chloroform	MCnc	Pt	Bld	Qn	null	DRUG/TOX	1	Chloroform [Mass/volume] in Blood	Chloroform Bld-mCnc	null	ACTIVE	1.0i	2.73
93336-6	Bile acid	SRat	48H	Stool	Qn	null	CHEM	1	Bile acid [Moles/time] in 48 hour Stool	Bile Ac 48h Stl-sRate	null	ACTIVE	2.67	2.67
93337-4	Chenodeoxycholate+Cholate/Bile acid.total	SFr	48H	Stool	Qn	null	CHEM	1	Chenodeoxycholate+Cholate/Bile acid.total in 48 hour Stool	CDCA+CA 48h SFr Stl	null	ACTIVE	2.67	2.67
93338-2	Bile acid panel	-	48H	Stool	-	null	PANEL.CHEM	1	Bile acid panel - 48 hour Stool	Bile acid pnl Stl	null	ACTIVE	2.67	2.67
93339-0	Thrombospondin type I domain-containing 7A Ab.IgG	PrThr	Pt	Ser/Plas	Ord	IF	SERO	1	THSD7A IgG Ab [Presence] in Serum or Plasma by Immunofluorescence	THSD7A IgG SerPl Ql IF	null	ACTIVE	2.67	2.67
93340-8	PhenX - complete blood count protocol 220501	-	Pt	^Patient	-	PhenX	PANEL.PHENX	2	PhenX - complete blood count protocol 220501	PhenX - CBC protocol	null	ACTIVE	2.67	2.67
93341-6	Medication recommendation	Imp	Pt	^Patient	Nar	null	MEDS	2	Medication recommendation	Medication recommendation	null	ACTIVE	2.67	2.67
93342-4	Power level^peak during exercise	EngRat	Pt	^Patient	Qn	null	CLIN	2	Power level --peak during exercise	Power lev peak W exer	null	ACTIVE	2.67	2.67
93343-2	Treatment to which interaction between genetic variants confers synergy	Prid	Pt	Bld/Tiss	Nom	null	MOLPATH	1	Treatment to which interaction between genetic variants confers synergy [Identifier] in Blood or Tissue Nominal	Variant interaction assoc therapy syner	null	ACTIVE	2.67	2.67

93246-7

Wish to be dead

Find

1Mo

^Patient

Ord

null

SURVEY.CSSRS

4

Wish to be dead 1 month

null

ACTIVE

2.67

93247-5

Non-specific active suicidal thoughts

Find

1Mo

^Patient

Ord

null

SURVEY.CSSRS

4

Non-specific active suicidal thoughts 1 month

null

ACTIVE

2.67

93248-3

Active suicidal ideation with any methods (not plan) without intent to act

Find

1Mo

^Patient

Ord

null

SURVEY.CSSRS

4

Active suicidal ideation with any methods (not plan) without intent to act 1 month

null

ACTIVE

2.67

93249-1

Active suicidal ideation with some intent to act, without specific plan

Find

1Mo

^Patient

Ord

null

SURVEY.CSSRS

4

Active suicidal ideation with some intent to act, without specific plan 1 month

null

ACTIVE

2.67

93250-9

Active suicidal ideation with specific plan and intent

Find

1Mo

^Patient

Ord

null

SURVEY.CSSRS

4

Active suicidal ideation with specific plan and intent 1 month

null

ACTIVE

2.67

93251-7

Duration of most severe suicidal ideation

Find

Lifetime

^Patient

Ord

C-SSRS

SURVEY.CSSRS

4

Duration of most severe suicidal ideation Lifetime [C-SSRS]

null

ACTIVE

2.67

9325-2

Tryptophan

SCnc

24H

Urine

Qn

null

CHEM

1

Tryptophan [Moles/volume] in 24 hour Urine

Tryptophan 24h Ur-sCnc

null

ACTIVE

1.0i

2.7

93252-5

Duration of most severe suicidal ideation

Find

1Mo

^Patient

Ord

C-SSRS

SURVEY.CSSRS

4

Duration of most severe suicidal ideation 1 month [C-SSRS]

null

ACTIVE

2.67

93253-3

Actual suicide attempt

Find

Lifetime

^Patient

Ord

null

SURVEY.CSSRS

4

Actual suicide attempt Lifetime

null

ACTIVE

2.67

93254-1

Actual suicide attempts

Num

Lifetime

^Patient

Qn

null

SURVEY.CSSRS

4

Actual suicide attempts # Lifetime

null

ACTIVE

2.67

93255-8

Actual suicide attempt

Find

3Mo

^Patient

Ord

null

SURVEY.CSSRS

4

Actual suicide attempt 3 months

null

ACTIVE

2.67

93256-6

Actual suicide attempts

Num

3Mo

^Patient

Qn

null

SURVEY.CSSRS

4

Actual suicide attempts # 3 months

null

ACTIVE

2.67

93257-4

Has subject engaged in non-suicidal self-injurious behavior

Find

Lifetime

^Patient

Ord

null

SURVEY.CSSRS

4

Has subject engaged in non-suicidal self-injurious behavior Lifetime

null

ACTIVE

2.67

93258-2

Has subject engaged in non-suicidal self-injurious behavior

Find

3Mo

^Patient

Ord

null

SURVEY.CSSRS

4

Has subject engaged in non-suicidal self-injurious behavior 3 months

null

ACTIVE

2.67

93259-0

Interrupted suicide attempt

Find

Lifetime

^Patient

Ord

null

SURVEY.CSSRS

4

Interrupted suicide attempt Lifetime

null

ACTIVE

2.67

9326-0

Phosphatidylserine Ab.IgG

PrThr

Pt

Ser

Ord

IA

COAG

1

Phosphatidylserine IgG Ab [Presence] in Serum by Immunoassay

PS IgG Ser Ql IA

null

ACTIVE

1.0i

2.73

93260-8

Interrupted suicide attempts

Num

Lifetime

^Patient

Qn

null

SURVEY.CSSRS

4

Interrupted suicide attempts # Lifetime

null

ACTIVE

2.67

93261-6

Interrupted suicide attempt

Find

3Mo

^Patient

Ord

null

SURVEY.CSSRS

4

Interrupted suicide attempt 3 months

null

ACTIVE

2.67

93262-4

Interrupted suicide attempts

Num

3Mo

^Patient

Qn

null

SURVEY.CSSRS

4

Interrupted suicide attempts # 3 months

null

ACTIVE

2.67

93263-2

Aborted or self-interrupted suicide attempt

Find

Lifetime

^Patient

Ord

null

SURVEY.CSSRS

4

Aborted or self-interrupted suicide attempt Lifetime

null

ACTIVE

2.67

93264-0

Aborted or self-interrupted suicide attempts

Num

Lifetime

^Patient

Qn

null

SURVEY.CSSRS

4

Aborted or self-interrupted suicide attempts # Lifetime

null

ACTIVE

2.67

93265-7

Aborted or self-interrupted suicide attempt

Find

3Mo

^Patient

Ord

null

SURVEY.CSSRS

4

Aborted or self-interrupted suicide attempt 3 months

null

ACTIVE

2.67

93266-5

Aborted or self-interrupted suicide attempts

Num

3Mo

^Patient

Qn

null

SURVEY.CSSRS

4

Aborted or self-interrupted suicide attempts # 3 months

null

ACTIVE

2.67

93267-3

Preparatory acts or suicidal behavior

Find

Lifetime

^Patient

Ord

null

SURVEY.CSSRS

4

Preparatory acts or suicidal behavior Lifetime

null

ACTIVE

2.67

93268-1

Preparatory acts or suicidal behaviors

Num

Lifetime

^Patient

Qn

null

SURVEY.CSSRS

4

Preparatory acts or suicidal behaviors # Lifetime

null

ACTIVE

2.67

93269-9

Preparatory acts or suicidal behavior

Find

3Mo

^Patient

Ord

null

SURVEY.CSSRS

4

Preparatory acts or suicidal behavior 3 months

null

ACTIVE

2.67

93270-7

Preparatory acts or suicidal behaviors

Num

3Mo

^Patient

Ord

null

SURVEY.CSSRS

4

Preparatory acts or suicidal behaviors # 3 months

null

ACTIVE

2.67

93271-5

Actual lethality or medical damage most lethal suicide attempt

Find

Lifetime

^Patient

Ord

C-SSRS

SURVEY.CSSRS

4

Actual lethality/medical damage most lethal suicide attempt Lifetime [C-SSRS]

null

ACTIVE

2.67

93272-3

Potential lethality most lethal suicide attempt

Find

Lifetime

^Patient

Ord

C-SSRS

SURVEY.CSSRS

4

Potential lethality most lethal suicide attempt Lifetime [C-SSRS]

null

ACTIVE

2.67

93275-6

Date of most lethal suicide attempt

Date

Pt

^Patient

Qn

null

SURVEY.CSSRS

4

Date of most lethal suicide attempt

null

ACTIVE

2.67

9327-8

Phosphatidylserine Ab.IgM

PrThr

Pt

Ser

Ord

IA

COAG

1

Phosphatidylserine IgM Ab [Presence] in Serum by Immunoassay

PS IgM Ser Ql IA

null

ACTIVE

1.0i

2.73

93278-0

Suicidal ideation

-

Pt

^Patient

-

C-SSRS

PANEL.SURVEY.CSSRS

4

Suicidal ideation [C-SSRS]

null

ACTIVE

2.67

93279-8

Most severe suicidal ideation description

Find

1Mo

^Patient

Nom

null

SURVEY.CSSRS

4

Most severe suicidal ideation description 1 month

null

ACTIVE

2.67

93280-6

Most severe suicidal ideation description

Find

Lifetime

^Patient

Nom

null

SURVEY.CSSRS

4

Most severe suicidal ideation description Lifetime

null

ACTIVE

2.67

93281-4

Potential lethality initial or first suicide attempt

Find

Pt

^Patient

Ord

C-SSRS

SURVEY.CSSRS

4

Potential lethality initial/first suicide attempt [C-SSRS]

null

ACTIVE

2.67

93282-2

Potential lethality most recent suicide attempt

Find

Pt

^Patient

Ord

C-SSRS

SURVEY.CSSRS

4

Potential lethality most recent suicide attempt [C-SSRS]

null

ACTIVE

2.67

93283-0

Actual lethality or medical damage initial or first suicide attempt

Find

Pt

^Patient

Ord

C-SSRS

SURVEY.CSSRS

4

Actual lethality/medical damage initial/first suicide attempt type [C-SSRS]

null

ACTIVE

2.67

93284-8

Actual lethality or medical damage most recent suicide attempt

Find

Pt

^Patient

Ord

C-SSRS

SURVEY.CSSRS

4

Actual lethality/medical damage most recent suicide attempt [C-SSRS]

null

ACTIVE

2.67

93285-5

Reasons for most severe suicidal ideation

Find

1Mo

^Patient

Ord

C-SSRS

SURVEY.CSSRS

4

Reasons for most severe suicidal ideation 1 month [C-SSRS]

null

ACTIVE

2.67

9328-6

Carbidopa

MCnc

Pt

Ser/Plas

Qn

null

DRUG/TOX

1

Carbidopa [Mass/volume] in Serum or Plasma

Carbidopa SerPl-mCnc

null

ACTIVE

1.0i

2.73

93286-3

Reasons for most severe suicidal ideation

Find

Lifetime

^Patient

Ord

C-SSRS

SURVEY.CSSRS

4

Reasons for most severe suicidal ideation Lifetime [C-SSRS]

null

ACTIVE

2.67

93287-1

Deterrents of most severe suicidal ideation

Find

1Mo

^Patient

Ord

C-SSRS

SURVEY.CSSRS

4

Deterrents of most severe suicidal ideation 1 month [C-SSRS]

null

ACTIVE

2.67

93288-9

Deterrents of most severe suicidal ideation

Find

Lifetime

^Patient

Ord

C-SSRS

SURVEY.CSSRS

4

Deterrents of most severe suicidal ideation Lifetime [C-SSRS]

null

ACTIVE

2.67

93289-7

Controllability of most severe suicidal ideation

Find

1Mo

^Patient

Ord

C-SSRS

SURVEY.CSSRS

4

Controllability of most severe suicidal ideation 1 month [C-SSRS]

null

ACTIVE

2.67

93290-5

Controllability of most severe suicidal ideation

Find

Lifetime

^Patient

Ord

C-SSRS

SURVEY.CSSRS

4

Controllability of most severe suicidal ideation Lifetime [C-SSRS]

null

ACTIVE

2.67

93291-3

Frequency of most severe suicidal ideation

Find

1Mo

^Patient

Ord

C-SSRS

SURVEY.CSSRS

4

Frequency of most severe suicidal ideation 1 month [C-SSRS]

null

ACTIVE

2.67

93292-1

Frequency of most severe suicidal ideation

Find

Lifetime

^Patient

Ord

C-SSRS

SURVEY.CSSRS

4

Frequency of most severe suicidal ideation Lifetime [C-SSRS]

null

ACTIVE

2.67

93293-9

Most severe suicidal ideation

Type

1Mo

^Patient

Ord

null

SURVEY.CSSRS

4

Most severe suicidal ideation 1 month

null

ACTIVE

2.67

9329-4

Basement membrane Ab

ACnc

Pt

Ser

Qn

IA

SERO

1

Basement membrane Ab [Units/volume] in Serum by Immunoassay

BM Ab Ser IA-aCnc

null

ACTIVE

1.0i

2.73

93294-7

Most severe suicidal ideation

Type

Lifetime

^Patient

Ord

null

SURVEY.CSSRS

4

Most severe suicidal ideation Lifetime

null

ACTIVE

2.67

93295-4

Active suicidal ideation with specific plan and intent

Find

Lifetime

^Patient

Ord

null

SURVEY.CSSRS

4

Active suicidal ideation with specific plan and intent Lifetime

null

ACTIVE

2.67

93296-2

Active suicidal ideation with some intent to act, without specific plan

Find

Lifetime

^Patient

Ord

null

SURVEY.CSSRS

4

Active suicidal ideation with some intent to act, without specific plan Lifetime

null

ACTIVE

2.67

93297-0

Active suicidal ideation with any methods (not plan) without intent to act

Find

Lifetime

^Patient

Ord

null

SURVEY.CSSRS

4

Active suicidal ideation with any methods (not plan) without intent to act Lifetime

null

ACTIVE

2.67

93298-8

Non-specific active suicidal thoughts

Find

Lifetime

^Patient

Ord

null

SURVEY.CSSRS

4

Non-specific active suicidal thoughts Lifetime

null

ACTIVE

2.67

2.7

93299-6

Wish to be dead

Find

Lifetime

^Patient

Ord

null

SURVEY.CSSRS

4

Wish to be dead Lifetime

null

ACTIVE

2.67

2.7

93301-0

Date of initial or first suicide attempt

Date

Pt

^Patient

Qn

null

SURVEY.CSSRS

4

Date of initial/first suicide attempt

null

ACTIVE

2.67

9330-2

Benzene

MCnc

Pt

Bld

Qn

null

DRUG/TOX

1

Benzene [Mass/volume] in Blood

Benzene Bld-mCnc

null

ACTIVE

1.0i

2.73

93302-8

Date of most recent suicide attempt

Date

Pt

^Patient

Qn

null

SURVEY.CSSRS

4

Date of most recent suicide attempt

null

ACTIVE

2.67

93303-6

Intensity of ideation

-

Pt

^Patient

-

C-SSRS

PANEL.SURVEY.CSSRS

4

Intensity of ideation [C-SSRS]

null

ACTIVE

2.67

93304-4

Suicidal behavior

-

Pt

^Patient

-

C-SSRS

PANEL.SURVEY.CSSRS

4

Suicidal behavior [C-SSRS]

null

ACTIVE

2.67

2.68

93305-1

Lethality

-

Pt

^Patient

-

C-SSRS

PANEL.SURVEY.CSSRS

4

Lethality [C-SSRS]

null

ACTIVE

2.67

93306-9

Genetic risk score for coronary heart disease

Score

Lifetime

^Patient

Qn

null

CLIN.RISK

2

Genetic risk score for coronary heart disease

GRS for CHD

null

ACTIVE

2.67

93307-7

Lifetime risk for developing coronary heart disease based on genetic risk score

Likelihood

Lifetime

^Patient

Ord

null

CLIN.RISK

2

Lifetime risk for developing coronary heart disease based on genetic risk score

Lifetime Risk for CHD based on GRS

null

ACTIVE

2.67

93308-5

Risk of adverse drug reaction sequence variation interpretation

Imp

Pt

Bld/Tiss

Nar

null

MOLPATH.PHARMG

1

Genetic variation's effect on risk of adverse drug reaction

Adverse drug seq var interp Bld/T-Imp

null

TRIAL

2.67

93309-3

Hearing.ability to hear during 3D assessment period

Find

3D

^Patient

Ord

CMS Assessment

SURVEY.CMS

4

Hearing.ability to hear during 3 day assessment period [CMS Assessment]

null

ACTIVE

2.67

9331-0

Boron

MCnc

Pt

Urine

Qn

null

DRUG/TOX

1

Boron [Mass/volume] in Urine

Boron Ur-mCnc

null

ACTIVE

1.0i

2.73

93310-1

Vision.ability to see in adequate light during 3D assessment period

Find

3D

^Patient

Ord

CMS Assessment

SURVEY.CMS

4

Vision.ability to see in adequate light during 3 day assessment period [CMS Assessment]

null

ACTIVE

2.67

93313-5

Platelet glycoprotein disorder

Imp

Pt

Bld

Nar

Flow cytometry

CELLMARK

1

Platelet glycoprotein disorder [Interpretation] in Blood by Flow cytometry (FC) Narrative

Platelet GP disorder Bld FC-Imp

null

ACTIVE

2.67

93314-3

Platelet glycoprotein VI actual/normal

RelRto

Pt

Bld

Qn

Flow cytometry

CELLMARK

1

Platelet glycoprotein VI actual/normal in Blood by Flow cytometry (FC)

Plt GPVI Act/Nor Bld FC

null

ACTIVE

2.67

93315-0

Platelet CD49b actual/normal

RelRto

Pt

Bld

Qn

Flow cytometry

CELLMARK

1

Platelet CD49b actual/normal in Blood by Flow cytometry (FC)

Plt CD49b Act/Nor Bld FC

null

ACTIVE

2.67

93316-8

Platelet CD42b actual/normal

RelRto

Pt

Bld

Qn

Flow cytometry

CELLMARK

1

Platelet CD42b actual/normal in Blood by Flow cytometry (FC)

Plt CD42b Act/Nor Bld FC

null

ACTIVE

2.67

93317-6

Platelet CD42a actual/normal

RelRto

Pt

Bld

Qn

Flow cytometry

CELLMARK

1

Platelet CD42a actual/normal in Blood by Flow cytometry (FC)

Plt CD42a Act/Nor Bld FC

null

ACTIVE

2.67

93318-4

Platelet CD61 actual/normal

RelRto

Pt

Bld

Qn

Flow cytometry

CELLMARK

1

Platelet CD61 actual/normal in Blood by Flow cytometry (FC)

Plt CD61 Act/Nor Bld FC

null

ACTIVE

2.67

93319-2

Platelet CD41 actual/normal

RelRto

Pt

Bld

Qn

Flow cytometry

CELLMARK

1

Platelet CD41 actual/normal in Blood by Flow cytometry (FC)

Plt CD41 Act/Nor Bld FC

null

ACTIVE

2.67

933-2

Blood product type

Type

Pt

^BPU

Nom

null

BLDBK

1

Blood product type

Bld Prod Typ BPU

null

ACTIVE

1.0

2.73

93320-0

Platelet glycoprotein disorder panel

-

Pt

Bld

Qn

Flow cytometry

PANEL.CELLMARK

1

Platelet surface glycoprotein disorders panel - Blood by Flow cytometry (FC)

Platelet glycoprotein Pnl Bld FC

null

ACTIVE

2.67

93321-8

PT mixing study panel

-

Pt

PPP

Qn

Coag

PANEL.COAG

1

PT mixing study panel - Platelet poor plasma by Coagulation assay

PT mix Pnl PPP

null

ACTIVE

2.67

93323-4

Tauroursodeoxycholate

SCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Tauroursodeoxycholate [Moles/volume] in Serum or Plasma

TUDCA SerPl-sCnc

null

ACTIVE

2.67

93324-2

Taurolithocholate

SCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Taurolithocholate [Moles/volume] in Serum or Plasma

TLCA SerPl-sCnc

null

ACTIVE

2.67

93325-9

Taurohyodeoxycholate

SCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Taurohyodeoxycholate [Moles/volume] in Serum or Plasma

THDCA SerPl-sCnc

null

ACTIVE

2.67

93326-7

Taurodeoxycholate

SCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Taurodeoxycholate [Moles/volume] in Serum or Plasma

TDCA SerPl-sCnc

null

ACTIVE

2.67

93327-5

Taurocholate

SCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Taurocholate [Moles/volume] in Serum or Plasma

TCA SerPl-sCnc

null

ACTIVE

2.67

9332-8

Carbon tetrachloride

MCnc

Pt

Bld

Qn

null

DRUG/TOX

1

Carbon tetrachloride [Mass/volume] in Blood

Carbon Tet Bld-mCnc

null

ACTIVE

1.0i

2.73

93328-3

Taurochenodeoxycholate

SCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Taurochenodeoxycholate [Moles/volume] in Serum or Plasma

TCDCA SerPl-sCnc

null

ACTIVE

2.67

93329-1

Hyodeoxycholate

SCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Hyodeoxycholate [Moles/volume] in Serum or Plasma

HDCA SerPl-sCnc

null

ACTIVE

2.67

93330-9

Glycoursodeoxycholate

SCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Glycoursodeoxycholate [Moles/volume] in Serum or Plasma

GUDCA SerPl-sCnc

null

ACTIVE

2.67

93331-7

Glycolithocholate

SCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Glycolithocholate [Moles/volume] in Serum or Plasma

GLCA SerPl-sCnc

null

ACTIVE

2.67

93332-5

Glycohyodeoxycholate

SCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Glycohyodeoxycholate [Moles/volume] in Serum or Plasma

Glycohyodeoxycholate SerPl-sCnc

null

ACTIVE

2.67

93333-3

Glycodeoxycholate

SCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Glycodeoxycholate [Moles/volume] in Serum or Plasma

GDCA SerPl-sCnc

null

ACTIVE

2.67

93334-1

Glycocholate

SCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Glycocholate [Moles/volume] in Serum or Plasma

GCA SerPl-sCnc

null

ACTIVE

2.67

93335-8

Glycochenodeoxycholate

SCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Glycochenodeoxycholate [Moles/volume] in Serum or Plasma

GCDCA SerPl-sCnc

null

ACTIVE

2.67

9333-6

Chloroform

MCnc

Pt

Bld

Qn

null

DRUG/TOX

1

Chloroform [Mass/volume] in Blood

Chloroform Bld-mCnc

null

ACTIVE

1.0i

2.73

93336-6

Bile acid

SRat

48H

Stool

Qn

null

CHEM

1

Bile acid [Moles/time] in 48 hour Stool

Bile Ac 48h Stl-sRate

null

ACTIVE

2.67

93337-4

Chenodeoxycholate+Cholate/Bile acid.total

SFr

48H

Stool

Qn

null

CHEM

1

Chenodeoxycholate+Cholate/Bile acid.total in 48 hour Stool

CDCA+CA 48h SFr Stl

null

ACTIVE

2.67

93338-2

Bile acid panel

-

48H

Stool

-

null

PANEL.CHEM

1

Bile acid panel - 48 hour Stool

Bile acid pnl Stl

null

ACTIVE

2.67

93339-0

Thrombospondin type I domain-containing 7A Ab.IgG

PrThr

Pt

Ser/Plas

Ord

IF

SERO

1

THSD7A IgG Ab [Presence] in Serum or Plasma by Immunofluorescence

THSD7A IgG SerPl Ql IF

null

ACTIVE

2.67

93340-8

PhenX - complete blood count protocol 220501

-

Pt

^Patient

-

PhenX

PANEL.PHENX

2

PhenX - complete blood count protocol 220501

PhenX - CBC protocol

null

ACTIVE

2.67

93341-6

Medication recommendation

Imp

Pt

^Patient

Nar

null

MEDS

2

Medication recommendation

null

ACTIVE

2.67

93342-4

Power level^peak during exercise

EngRat

Pt

^Patient

Qn

null

CLIN

2

Power level --peak during exercise

Power lev peak W exer

null

ACTIVE

2.67

93343-2

Treatment to which interaction between genetic variants confers synergy

Prid

Pt

Bld/Tiss

Nom

null

MOLPATH

1

Treatment to which interaction between genetic variants confers synergy [Identifier] in Blood or Tissue Nominal

Variant interaction assoc therapy syner

null

ACTIVE

2.67